27 results
8-K
EX-2.1
MACA
Moringa Acquisition Corp - Ordinary Shares
3 Apr 24
Entry into a Material Definitive Agreement
11:22am
has unfunded liabilities that will not be offset by insurance or that are not fully accrued on the Financial Statements; and (viii) the consummation
8-K
EX-2.1
MACA
Moringa Acquisition Corp - Ordinary Shares
26 Feb 24
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
5:29pm
to the Group Companies taken as a whole; (vii) no Foreign Plan has unfunded liabilities that will not be offset by insurance or that are not fully
425
EX-10.4.6
bug422rfrbtu9kv9 prh
13 Jun 22
Business combination disclosure
5:15pm
8-K
EX-10.4.6
iatmlkhdxekar3
13 Jun 22
There’s always a better travel deal out there INVESTOR PRESENTATION JUNE 2022
5:12pm
10-Q
wkaoyf
25 May 21
Quarterly report
5:06pm
10-K
oo52q
31 Mar 21
Annual report
5:15pm
8-K
EX-10.8
5esdia0pd a1qk
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.12
tckonbnrs yy5rq6a2y
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.9
1j7d42xmmc8f0
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.11
99b4ozui ie0a6mt062
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm